Prognosticheskaya rol' kliniko-sotsial'nykh faktorov v otsenke effektivnosti farmakoterapii u bol'nykh s nepsikhoticheskimi depressiyami
- Authors: Kanaeva L.S1, Avedisova A.S1
-
Affiliations:
- Issue: No 10 (2014)
- Pages: 45-52
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/287021
- ID: 287021
Cite item
Abstract
This article provides a comprehensive analysis of the effectiveness of different options of timoanaleptic therapy. Identified sociodemographic and clinical characteristics of patients who achieved remission and suboptimal responses (response, partial response and non-response), will allow to predict the of efficacy at the stage of treatment planning and optimize provided treatment at early stages.
Full Text

References
- Macher J.P., Crocq M.A. Treatment goals: response and nonresponse // Dialogues Clin. Neurosci. 2004. Vol. 6(1). P. 83-91.
- Prien R.F., Carpenter L.L., Kupfer D.J. The definition and operational criteria for treatment outcome of major depressive disorder // Arch. Gen. Psychiatryy. 1991. Vol. 48. P. 796-800.
- Аведисова А.С. Ремиссия при терапии антидепрессантами - признак стабилизации состояния или снижения активности процесса?// Психиатрия и психофармакотер. 2008. № 2.
- Rush A.J., Thase M.E., Dube S. Research issues in the study of difficult-to-treat depression// Biol. Psychiatr. 2003. Vol. 53. P. 743-53.
- Fava M., Evins A.E., Dorer D.J., Schoenfeld D.A. The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach // Psychother. Psychosom. 2003. Vol. 72. P. 115-27.
- Frank E., Prien R.F., Jarrett R.B., et al. Conceptualization and Rationale for Consensus Definitions of Terms in Major Depressive Disorder Remission, Recovery, Relapse, and Recurrence // Arch. Gen. Psychiatry. 1991. Vol. 48. P. 851-55.
- Rush A.J., Kraemer H.C., et al. Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder // Neuropsychopharmacol. 2006. Vol. 31. P. 1841-53.
- Keller M.B. Past, Present, and Future Directions for Defining Optimal Treatment Outcome in Depression. Remission and Beyond // JAMA. 2003. Vol. 289(23). P. 3152-60.
- Guilloux J.P., David D.J., Samuels B.A., et al. Non-Response to Initial Antidepressant Therapy. Psychology -Selected Papers Edited by Dr. Gina Rossi, 2012. P. 85-106.
- Ferrier I.N. Treatment of major depression: is improvement enough? // J. Clin. Psychiatry. 1999. Vol. 60(Suppl. 6). P. 10-4.
- Rush A.J. Recent Advances in the Management of Major Depression: An Evidence-Based Approach. Psych CME REPORTS, 2007. P. 1-8.
- Müller H.J. Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment // World J. Biol. Psychiatry. 2008. Vol. 9(2). P. 102-14.
- Husain M.M., Rush A.J., Fink M., et al. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a consortium for research in ECT (CORE) report // J. Clin. Psychiatry. 2004. Vol. 65. P. 485-91.
- Мосолов С.Н. Клиническое применение современных антидепрессантов. СПб., 1995. 568 с.
- Rubinow D.R. Sex-dependent modulation of treatment response // Dialogues Clin. Neurosci. 2004. Vol. 6(1). P. 39-51.
- Вертоградова О.П. Общие принципы терапии и прогноза депрессий / Сб. научных трудов "Психопатологические и патогенетические аспекты прогноза и терапии депрессий". 1985. C. 5-10.
- Вельтищев Д.Ю. Клинико-патогенетические закономерности ситуационных расстройств депрессивного спектра. Дисс. докт. мед. наук. 2000.
- Краснов В.Н. Расстройства аффективного спектра. М., 2011. 432 с.
- Захарова К.В. Качество и стойкость ремиссии при применении фармакотерапии у больных с депрессивными расстройствами. Дисc. канд. мед. наук. М., 2008.
- Scheibe S, Preuschhof C, Cristi C, et al. Are there gender differences in major depression and its response to antidepressants?//J. Affect Disord. 2003. Vol. 75(3). P. 223-35.
- Akiskal H.S. Dysthymic disorder: psychopathology of proposed chronic depressive subtypes // Am. J. Psychiat. 1983. Vol. 140. P. 11-20.
- Souery D., Oswald P., Massat I., et al. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study // J. Clin. Psychiat. 2007. Vol. 68(7). P. 1062-70.
- Dudek D., Rybakowski J.K., Siwek M,, et al. Risk factors of treatment resistance in major depression: association with bipolarity// J. Affect Disord. 2010. Vol. 126(1-2). P. 268-71.
- Rush A.J., Wisniewski S.R., Warden D., et al. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features // Arch. Gen. Psychiatry. 2008. Vol. 65(8). P. 870-80.
- Frank E., Cassano G.B., Rucci P., et al. Predictors and Moderators of Time to Remission of Major Depression with Interpersonal Psychotherapy and SSRI Pharmacotherapy // Psychol. Med. 2011. Vol. 41(1). P. 151-62.
- Sotsky S.M., Glass D.R., Shea T., et al. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program // Am. J. Psychiatr. 1991. Vol. 148. P. 997-1008.
- Мазо Г.Э., Иванов М.В., Вовин Р.Я. Терапевтическая динамика и предикторы ответа на терапию при использовании селективных серотонинергических антидепрессантов // Психиатрия и психофармакотер. 2003. Т. 5. № 2.
- Андрющенко А.В. Выбор терапии при соматизированных депрессиях // РМЖ. 1998. Т. 1. № 2.
- Банников Г.С. Роль личностных особенностей в формировании структуры депрессии и реакций дезадаптации. Дисс. канд. мед. наук. М., 1998.
- Краснов В.Н., Гурович И.Я. Модели диагностики и лечения психических и поведенческих расстройств: Клиническое руководство // Соц. и клин. психиатрия. (Прил.) 1999. С. 97-109.
- Petrilowitsch N., Baer R. Psychopathie 19451966 (Teil 2) // Fortschr. Keiirol. Psychiat. 1967. Vol. 35. P. 627.
- Parker G., Tennant C., Blignault I. Predicting improvement in patients with non-endoge-nous depression // Br. J. Psychiat. 1985. 146. P. 132-39.
Supplementary files
